Gal9/TIM-3 Expression Levels Affects Chemotherapy in Leukemia Patients

A new report suggests targeting the Gal9/TIM3-axis could help boost chances of complete remission in patients with acute myeloid leukemia.

Source: CancerNetwork - August 22, 2019 Category: Cancer & Oncology Authors: John Schieszer Source Type: news